BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 606 found
  Current Search:  osteoporosi: 606     

HTML
100%
Drug Cures Osteoporosis in Mice
MONDAY, Feb.

8 (HealthDay News) -- An experimental drug that inhibits serotonin in the gut cured osteoporosis in lab mice and rats, a new study has found.

Previous research has shown that serotonin in the gut hinders bone formation.

Most current...

MedicineNet.com:  Feb 9 2010 4:17PM
Matching: osteoporosi
Find similar documents
HTML
100%
Serotonin May Be a Key to Treat Osteoporosis
Study Shows Experimental Drug May Build New Bone by Decreasing Serotonin Levels in the Gut Feb.

7, 2010 -- The hormone serotonin may hold the key to new treatments for reversing osteoporosis-related bone loss, new research finds.

When investigators at...

MedicineNet.com:  Feb 9 2010 4:21PM
Matching: osteoporosi
Find similar documents
HTML
100%
Inhibiting Serotonin In Gut Could Cure Osteoporosis
An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb.

7...

Medical News Today:  Feb 9 2010 3:46PM
Matching: osteoporosi
Find similar documents
HTML
100%
Drug Found to Inhibit, Reverse Osteoporosis in Rodents
MONDAY, Feb.

8 (HealthDay News) -- An investigational drug that blocks the synthesis of serotonin in the gut prevents and reverses osteoporosis in a rodent model of the disease by promoting bone formation, according to a study published online Feb.

7...

Modern Medicine:  Feb 9 2010 1:01AM
Matching: osteoporosi
Find similar documents
HTML
100%
Working Life: Olivier Leupin
After receiving a masters degree in biology at the University of Lausanne, I travelled a long way down Lake Geneva to complete a Ph.D.

program at the University of Geneva in the department of microbiology and molecular medicine.

My research focused on the...

Pharmafocus:  Feb 9 2010 10:30AM
Matching: osteoporosi
Find similar documents
HTML
100%
Osteoporosis Could be Cured by Inhibiting Serotonin in Gut
An international team led by researchers from Columbia University Medical Center says that an investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats.

The study...

MedIndia:  Feb 9 2010 3:40AM
Matching: osteoporosi
Find similar documents
HTML
100%
Building Bones Complementary Approach in Osteoporosis Fight
In the Feb.

7, 2010, online edition of Nature Medicine, scientists described an anabolic approach to increasing bone mass: In rodents, they were able to increase osteoblast activity and, ultimately, bone mass and function, by inhibiting gut serotonin.

Bone...

Therapeutics Daily:  Feb 9 2010 2:23AM
Matching: osteoporosi
Find similar documents
HTML
100%
Medical News: Inhibiting Serotonin In Gut Could Cure Osteoporosis
An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb.

7...

BioFind:  Feb 9 2010 4:13PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.

(AP) -- Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.The drug, also called Prolia, is viewed by Wall Street...

Yahoo! Canada:  Feb 9 2010 4:09PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.

(AP) -- Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.The drug, also called Prolia, is viewed by Wall Street...

Yahoo! Canada:  Feb 9 2010 4:09PM
Matching: osteoporosi
Find similar documents
HTML
100%
Low level nicotine: A novel approach to reduce osteoporosis incidence
Zhang J et al.

Here, the authors review the clinical evidence on nicotine consumption and osteoporosis, and propose a possible protective mechanism.

It should be note that there is no strong clinical evidence that proves nicotine is detrimental.

MDLinx:  Feb 9 2010 11:38AM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.

(AP) ' Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.

The drug, also called Prolia, is viewed by Wall...

Bioscience Technology Online:  Feb 9 2010 6:28PM
Matching: osteoporosi
Find similar documents
HTML
100%
Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats
_ Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats.
Womens Health:  Feb 9 2010 6:17PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen Sees Positive Data In Bone Drug Study
THOUSAND OAKS, Calif.

-- Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.

The drug, also called Prolia, is viewed by Wall Street as...

Pharma Live:  Feb 9 2010 6:16PM
Matching: osteoporosi
Find similar documents
HTML
100%
New osteoporosis treatment available in the UK
Magnetic Resonance Therapy, or MBST, uses low-power magnetic resonance signals to stimulate the regeneration of damaged cartilage and bone cells.

Axel Muntermann, managing director of the German company who developed the treatment, said: 'With an aging...

Private Healthcare UK:  Feb 9 2010 6:15PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen Advances Effort To Sell Bone Drug For Cancer Patients
NEW YORK -(Dow Jones)- The third success of Amgen Inc.'s (AMGN) experimental bone drug denosumab in helping prevent bone complications in cancer patients increases the drug's chances of regulatory approval, even as the biotech awaits to bring the same drug to...
Nasdaq:  Feb 9 2010 6:14PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen Advances Effort To Sell Bone Drug For Cancer Patients
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- The third success of Amgen Inc.'s (AMGN) experimental bone drug denosumab in helping prevent bone complications in cancer patients increases the drug's chances of regulatory approval, even as the...
Lloyd's:  Feb 9 2010 6:12PM
Matching: osteoporosi
Find similar documents
HTML
100%
Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats
_ Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats.
Medscape:  Feb 9 2010 5:41PM
Matching: osteoporosi
Find similar documents
HTML
100%
Beer for Better Bones?
Beer Is a Rich Source of Bone-Boosting Silicon, Study Finds WebMD Health News Feb.

8, 2010 -- Drinking beer may be good for building more than just beer bellies.

A new study suggests that drinking beer may help build better bones thanks to its high silicon...

WebMD:  Feb 9 2010 5:31PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.

- Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.

The drug, also called Prolia, is viewed by Wall Street as...

Minneapolis Star Tribune:  Feb 9 2010 5:26PM
Matching: osteoporosi
Find similar documents
HTML
100%
Bone Up On This Potential Blockbuster
Investors patiently waiting for the Food and Drug Administration to approve Amgen's (Nasdaq: AMGN) bone drug Prolia may finally be seeing the light at the end of the tunnel.

Yesterday Amgen released positive results from its third phase 3 trial pitting Prolia...

Motley Fool via MSN Money:  Feb 9 2010 5:21PM
Matching: osteoporosi
Find similar documents
HTML
100%
Bone Up On This Potential Blockbuster
Investors patiently waiting for the Food and Drug Administration to approve Amgen's (Nasdaq: AMGN) bone drug Prolia may finally be seeing the light at the end of the tunnel.

Yesterday Amgen released positive results from its third phase 3 trial pitting Prolia...

Motley Fool:  Feb 9 2010 5:13PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.

Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.

The drug, also called Prolia, is viewed by Wall Street as...

El Paso Times:  Feb 9 2010 4:53PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.

Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.

The drug, also called Prolia, is viewed by Wall Street as...

Yahoo! Malaysia:  Feb 9 2010 4:42PM
Matching: osteoporosi
Find similar documents
HTML
100%
Amgen Sees Positive Data In Bone Drug Study
THOUSAND OAKS, Calif.

(AP) - Amgen Inc.

said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.The drug, also called Prolia, is viewed by Wall Street...

CBS News:  Feb 9 2010 4:26PM
Matching: osteoporosi
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.